EcoR1 Capital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001587114

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 34 positions · Total reported value $2.11B · Top-10 concentration 84.4% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.5% · 9 new · 4 cut · 6 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -3.0% · vs SPY -5.1% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.9% · vs SPY -1.2% · Latest Value $2.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, EcoR1 Capital, LLC disclosed 34 equity positions with a combined reported value of $2.11B. The filing implies a focused portfolio: its ten largest positions account for 84.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were ZYME ($608.49M), ANAB ($396.05M), BMY ($218.40M). By sector, the heaviest allocations are Health Care 96.5%, Financials 0.1%. Versus the prior quarter, allocation shifted toward Other (+0.8pp) and away from Health Care (-0.8pp).

Versus the prior quarter, EcoR1 Capital, LLC opened 9 new positions, trimmed 4 and fully exited 6, a turnover rate of 47.5% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q3 2026 were BMY ($218.40M), ANRO ($56.98M), ATOS ($34.69M).

Of the 6 positions fully exited versus the prior quarter, the largest were LEGN ($23.10M), MBX ($21.45M), RLAY ($13.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • BMY BRISTOL-MYERS SQUIBB CO · $218.40M
  • ANRO ALTO NEUROSCIENCE INC · $56.98M
  • ATOS ATTOVIA THERAPEUTICS INC · $34.69M
  • VNDA VANDA PHARMACEUTICALS INC · $22.93M
  • GRTX ELECTRA THERAPEUTICS INC · $19.12M
  • CAPR CAPRICOR THERAPEUTICS INC · $13.04M
  • XNCR XENCOR INC · $12.47M
  • TLGYF TCGX ACQUISITION CORP · $3.13M

Fully Exited (vs previous quarter)

  • LEGN LEGEND BIOTECH CORP · prev qtr: $23.10M
  • MBX MBX BIOSCIENCES INC · prev qtr: $21.45M
  • RLAY RELAY THERAPEUTICS INC · prev qtr: $13.06M
  • PHAT PHATHOM PHARMACEUTICALS INC · prev qtr: $6.78M
  • MREO MEREO BIOPHARMA GROUP PLC · prev qtr: $317.70K
  • SRZNW SURROZEN INC · prev qtr: $115.32K

Insider Transactions (Form 4)

Latest EcoR1 Capital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-07 Buy Atara Biotherapeutics, Inc. 507,407 $9.35 SEC filing
2026-04-20 Sell First Tracks Biotherapeutics, Inc. 4,705,575 $13.81 SEC filing

All insider transactions →

Fund Profile

EcoR1 Capital, LLC, based in San Francisco, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 31 positions worth $1.95B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-100470 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $3.42B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds

Portfolio Structure

  • 31 positions · $1.95B reported value (Q2 2026)
  • Top 10 holdings = 87.7% of reported value
  • Largest position: ZYME (ZYMEWORKS INC) at 30.8%
  • Average position size: $62.85M

Sector Tilt

  • Health Care 97.3%
  • Financials 0.1%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 9 new, 2 added, 5 reduced, 7 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 96.5%
Financials 0.1%
Other 3.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 22.97M $608.49M 28.82%
28.82%
Hold
2 7.88M $396.05M 18.76%
18.76%
Hold
3 3.50M $218.40M 10.34%
10.34%
New
4 2.47M $127.23M 6.03%
6.03%
Add
5 3.17M $112.50M 5.33%
5.33%
Hold
6 4.82M $93.93M 4.45%
4.45%
Hold
7 1.39M $76.85M 3.64%
3.64%
Hold
8 2.23M $56.98M 2.70%
2.70%
New
9 1.67M $49.43M 2.34%
2.34%
Hold
10 2.95M $43.25M 2.05%
2.05%
Add
11 3.03M $40.79M 1.93%
1.93%
Reduce
12 1.27M $35.37M 1.68%
1.68%
Hold
13 2.02M $34.69M 1.64%
1.64%
New
14 6.80M $25.17M 1.19%
1.19%
Add
15 1.15M $22.93M 1.09%
1.09%
New
16 835.00K $21.71M 1.03%
1.03%
Add
17 789.50K $21.29M 1.01%
1.01%
Hold
18 1.70M $19.12M 0.91%
0.91%
New
19 1.55M $13.19M 0.62%
0.62%
Hold
20 1.38M $13.04M 0.62%
0.62%
New
21 500.00K $12.47M 0.59%
0.59%
New
22 555.55K $12.34M 0.58%
0.58%
Hold
23 1.67M $10.47M 0.50%
0.50%
Hold
24 375.00K $8.89M 0.42%
0.42%
Add
25 235.00K $7.45M 0.35%
0.35%
Hold
26 855.63K $6.88M 0.33%
0.33%
Add
27 400.00K $6.12M 0.29%
0.29%
Hold
28 720.03K $3.79M 0.18%
0.18%
Add
29 889.61K $3.65M 0.17%
0.17%
Reduce
30 250.00K $3.13M 0.15%
0.15%
New
31 679.72K $2.83M 0.13%
0.13%
Reduce
32 200.00K $2.12M 0.10%
0.10%
Hold
33 64.30K $862.95K 0.04%
0.04%
New
34 100 $7.09K 0.00%
0.00%
Reduce

FAQ

What did EcoR1 Capital, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, EcoR1 Capital, LLC reported 34 equity positions worth $2.11B in aggregate; its largest disclosed positions were ZYME ($608.49M), ANAB ($396.05M), BMY ($218.40M).

How large is EcoR1 Capital, LLC's portfolio?

EcoR1 Capital, LLC reported $2.11B of long equity holdings across 34 positions as of 2026-Q3. Top-10 holdings account for 84.4% of reported value.

What is EcoR1 Capital, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ecor1-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →